Revenue Disaggregation

3 Months Ended

Jun. 30, 2023

Revenue from Contract with Customer [Abstract]

Revenue Disaggregation

Note 10. Revenue Disaggregation

The Company generates product revenues from products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers.

The following table presents the Company’s disaggregated revenues by source: 

	Three Months Ended June 30,
Product	2023		2022
Human Care	$	2,750,000	$	2,168,000
Animal Care		578,000		787,000
Total Product		3,328,000		2,955,000
Service and Royalty		99,000		1,028,000
Total	$	3,427,000	$	3,983,000

The following table shows the Company’s revenues by geographic region: 

	Three Months Ended June 30,
	2023		2022
United States	$	806,000	$	871,000
Europe		1,070,000		841,000
Asia		862,000		920,000
Latin America		487,000		1,048,000
Rest of the World		202,000		303,000
Total	$	3,427,000	$	3,983,000

The Company’s service revenues in Latin America amounted to $99,000 and $1,028,000 for the three months ended June 30, 2023 and 2022, respectively.